The HS. Health-Tech Podcast

The HS. Health-Tech Podcast

By HS.Ventures
The HS. Health-Tech Podcast covers the latest in health and technology through interviews with disruptive health-tech startups and leaders. Whether youā€™re a patient, founder, investor or simply interested in health-tech, the HS. Health-Tech Podcast has it covered. šŸŒ Listeners in >80 countries. šŸŽ™ 2 new episodes every week. HS. is an innovation ecosystem that builds, scales and invests in the best healthtech companies. We work with founders, startup teams, health providers and corporates to improve health and patient care through innovation. www.hs.ventures
Where to listen
Apple Podcasts Logo
Breaker Logo
Castbox Logo
Google Podcasts Logo
Overcast Logo
Pocket Casts Logo
PodBean Logo
RadioPublic Logo
Spotify Logo
Stitcher Logo
Currently playing episode

Episode 30: The Story of Vincent Grasso, A Wall Street Legend and Extreme Telemedicine šŸ”

The HS. Health-Tech Podcast

Episode 30: The Story of Vincent Grasso, A Wall Street Legend and Extreme Telemedicine šŸ”

The HS. Health-Tech Podcast

Go to next audioGo to next audio
Go to prev audioGo to prev audio
1x
Episode 61: AI, Africa and A Ā£140k Investment šŸŒ
This week's Sunday Session - a short, sharp selection of Sunday inspiration featuring some bonus content from previous guests, recent healthtech news, recommendations for events, books, articles and some Q&A from all the comments and feedback. Mentioned this week: Episode 48: The Story of Skin Analytics and Dermatology AI: https://apple.co/2RoxSre Renovos Raise Ā£140k From The Ronald Furlong Fund: https://bit.ly/2FZMRCs The Africa Prize For Engineering Innovation, 23rd January 2020: https://bit.ly/38hifIR Big Brain Revolution, by Dr. Michelle Tempest: https://amzn.to/3ajlqS9 If you want to suggest a guest or appear on the podcast, email James a pitch at james@hs.live or if you want a question answered on one of the Sunday Sessions, send it to that email too or message him on his socials (below). If youā€™re interested in sponsoring the podcast, email us at info@hs.live to ask for our sponsorship brochure. If you want to pitch James a Forbes article or send him a press release, email him at js@somx.co.uk For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.live You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
09:01
January 19, 2020
Episode 60: The Story of Biobeats and Coding Human Behaviour šŸ¤–
Why do humans ignore their limitations to climb Everest, run multiple ultramarathons to their death?Ā Why do people bring food to funerals?Ā What happens when you measure heart rate variability of French bankers during Brexit?Ā This week, James is joined by David Plans, cofounder andĀ CEO at BioBeats, anĀ artificial intelligence company dedicated to understanding and promoting human wellbeing through preventative mental health. David describes himself as a psychology researcher and entrepreneur - his initial doctoral used AI to create adaptive media systems that imitated and queried the nature of human creativity. Heā€™s given papers and performances at SXSW, International Computer Music Conference, the European Conference on Artificial Life, IRCAM, the Darwin Symposium, and the Computer Arts Society in London. David is also currently pursuing a DPhil in cognitive neuroscience at the Social Cognition Lab, University of Oxford, with Geoff Bird. Interestingly, David's early research focused on computational intelligence approaches to understand and classify emotion in music making, which forced him to examine the psychophysiology of play, flow and stress. Having built technology (apps+sensors) that attempts to measure stress and interoception in neurotypical adults, he is now investigating the influence of interoceptive awareness on stress, as well as aspects of organisational behaviour surrounding empathy and vulnerability. David actually suffered a heart attack inĀ BrusselsĀ airport due to a combination of high-stress, malnutrition and lack of physical awareness of his health declining, so is now most interested in whether training interoceptive awareness through digital forms of biofeedback could contribute to better stress resilience and foster empathy. david@biobeats.com | biobeats.com/ | https://www.linkedin.com/in/davidplans/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:04:54
January 16, 2020
Episode 59: Understand Your Customer! šŸ’„
The second Sunday Session - a short, sharp selection of Sunday inspiration featuring some bonus content from previous guests, recent healthtech news, recommendations for events, books, articles and some Q&A from all the comments and feedback. This time, James brings you some bonus content from Episode 37 with Dr. Jud Brewer who holds the position of 4th most watched TED talk in 2016, with 12 million views. Jud is founder of MindSciences Inc developing digital therapeutics in the area of addiction, he is Director of Research and Innovation at the Mindfulness Center and associate professor in psychiatry at the School of Medicine at Brown University and research affiliate at MIT. Heā€™s also held research and teaching positions at Yale University and the University of Massachusettsā€™ Center for Mindfulness. As an addiction psychiatrist and internationally known expert in mindfulness training for treating addictions, Dr. Jud has developed and tested novel mindfulness programs for habit change, including both in-person and app-based treatments for smoking, emotional eating, and anxiety (Eat Right Now, Unwinding Anxiety and Craving to Quit). James' Forbes Article: https://www.forbes.com/sites/jamessomauroo/2020/01/10/kry-expands-further-with-155-million-investment-into-digital-health-platform/ Jud's TED Talk (>12 million views): https://www.ted.com/talks/judson_brewer_a_simple_way_to_break_a_bad_habit?language=en Episode 37: The Story of Jud Brewer, Mindsciences Inc and Mindful Tech šŸ“±: https://podcasts.apple.com/us/podcast/episode-37-story-jud-brewer-digital-therapeutics-mindful/id1438968893?i=1000447525669 HS Health-Tech Talks Event, 28 January: https://www.eventbrite.com/e/hs-health-tech-talks-growing-a-startup-registration-86471437397 If you want to suggest a guest or appear on the podcast, email James a pitch at james@hs.live or if you want a question answered on one of the Sunday Sessions, send it to that email too or message him on his socials (below). If youā€™re interested in sponsoring the podcast, email us at info@hs.live to ask for our sponsorship brochure. If you want to pitch James a Forbes article or send him a press release, email him at js@somx.co.uk For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.live You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
08:40
January 12, 2020
Episode 58: The Story of 'Changing Health' and Behaviour Change At Scale šŸš€
This week, James is joined byĀ ProfessorĀ MikeĀ Trenell,Ā one of the UK's leading lifestyle medicine researchers in digitalĀ healthĀ and diabetes having publishedĀ over 100 peer-reviewed papers.Ā MikeĀ is also aĀ ProfessorĀ of Metabolism & Lifestyle Medicine at Newcastle University, founding director of the NationalĀ HealthĀ Innovation Observatory andĀ the expert behind the BBC documentary,Ā 'How to Stay Young', where he used his background in weight management, diabetes and nutrition to inform the documentary's studies. Mike is currently imparting his expertise and background asĀ co-founder and chairman ofĀ health-tech companyĀ ChangingĀ Health,Ā a behaviouralĀ changeĀ platform for Type 2 diabetes management, prevention and weight loss. A load of lessons for entrepreneurs and those interested in health and technology this week, James and Mike discuss elite sport and tech, the value of good mentors shaping you, how weā€™re all standing on the shoulders of giants in healthtech right now and the changingĀ heath tech landscape through Mikeā€™s time in the sector. mike@changinghealth.com | @miketrenell | https://www.linkedin.com/in/michaeltrenell/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:01:33
January 9, 2020
Episode 57: The First Sunday Session šŸ¤“
The first Sunday Session episode - a short, sharp selection of Sunday inspiration featuring some bonus content from previous guests, recent healthtech news, recommendations for events, books, articles and some Q&A from all the comments and feedback. This time, James reflects on the podcast's growth to 84 countries through 2019 and previews some podcasts you might've missed over the Christmas period. James also mentions the next HS. Health-Tech Talks Event and tells you about his contributing writing to Forbes and how to get in touch with him to potentially write an article on your startup. 5 things I learned from healthtech podcasting in 2019: https://www.linkedin.com/pulse/5-things-i-learned-from-healthtech-podcasting-2019-dr-james-somauroo/ HS Health-Tech Talks Event, 28 January: https://www.eventbrite.com/e/hs-health-tech-talks-growing-a-startup-registration-86471437397 If you want to suggest a guest or appear on the podcast, email James a pitch at james@hs.live or if you want a question answered on one of the Sunday Sessions, send it to that email too or message him on his socials (below). And if youā€™re interested in sponsoring the podcast, email us at info@hs.live to ask for our sponsorship brochure. If you want to pitch James a Forbes article or send him a press release, email him at js@somx.co.uk For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
12:36
January 5, 2020
Episode 56: The Story of Sweatcoin and Public Health šŸƒšŸ¾ā€ā™€ļø
How do you go from investment banking and selling watches to becoming a healthtech entrepreneur? This week, James is joined byĀ Shaun Azam who runsĀ finance, operations and a whole lot more at Sweatcoin, a UK-based healthtech company on a mission to leave a mark on the world by helping every person on the planet be more active.Ā Sweatcoin is a digital currency backed by physical movement - they verify and convert movement into currency. Users can then donate to charity, transfer to other users or spend on products, services, and experiences provided by Sweatcoin vendors and user community. Sweatcoin tackles Present Bias by moving the future benefits of exercise into the here and now - immediately converting movement into a digital currency and changing the perception of physical movement.Ā In Janary 2018 they raisedĀ $5.7 million in a seed round led by Goodwater Capital with participation from Greylock Partners, Rubylight, Seedcamp, and SmartHub. Previously, Shaun built a consumer brand in his spare time to a six-figure business, worked in a global investment bank trading government bonds and advised some of the largest companies in the world on corporate strategy. James and Shaun discuss Shaun's hourney and what led him to Sweatcoin, how to escape the city, how to approach networking events to get opportunities in healthtech, how to build a business in public health, (there are B2B models that can work!) and a whole lot more. www.sweatco.in | shaun@sweatco.in | https://www.linkedin.com/in/shaunazam/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
45:58
January 2, 2020
Episode 55: The Story of Radiology AI with Dr. Hugh Harvey šŸ¦¾
How do you build an AI company in healthcare?Ā What can AI in radiology actually do? What should it be doing? Are clinicians ever going to be replaced? What does the future look like in healthcare AI? This week, James is joined by Dr. Hugh Harvey, who was a consultant radiologist before entering academia and completing an MD research degree in computational analysis of prostate MR, and winning science writer of the year twice in a row. Hugh worked as a consultant radiologist in the NHS (Guyā€™s and St. Thomasā€™ NHS Trust), and sat on the Royal College of Radiologists committee for medical imaging informatics as well as the AI working group. He now acts as a consultant and advisory board member for AI start-ups in the UK, EU and America within the imaging and healthcare space, as well as sitting on several AI and academic committeesĀ including the KSS Academic Health Science Network AI Core Advisory Group. He has co-authored several white papers and reports on AI in healthcare, alongside bodies such as Reform, an independent think-tank, and Health Education England and isĀ an associate editor at Nature: Digital Medicine. He acted as co-chair of the Topol Review, a seminal independent report for the UK Secretary of State for Health into preparing the healthcare workforce to deliver the digital future - read my take on the Topol Review for Forbes here: https://www.forbes.com/sites/jamessomauroo/2019/02/11/nhs-announces-workforce-plan-for-genomics-ai-and-digital-medicine/ And Hugh has deep start-up experience both as the lead for regulatory affairs at Babylon (recently valued >$1B) and then the Clinical Director at Kheiron Medical ($22M series A raise), where they developed deep learning software to improve breast cancer screening, and were the first UK company to receive the CE mark for a deep learning application in radiology. Hugh's unique career enables dynamic bridging between the medical, technical and business worlds, with academic, clinical and operational expertise in cognitive digital solutions. Heā€™s a pragmatist, a realist and incredibly refreshing and entertaining on social media @DrHughHarvey | hugh@hardianhealth.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
55:36
December 26, 2019
Episode 54: The Story of Novoheart and Artificial Organs šŸ’™
Can you grow a beating heart in a lab? Could you test cardiac drugs on it? Could you transplant it into a human? This week, James is joined byĀ Dr. Kevin Costa, Co-founder & Chief Scientific Officer at biotech firmĀ Novoheart, the first company in the world to have developed miniature beating human hearts from stemĀ cells which are being used to change the way drugs are able to be screened for cardiac effects.Ā The company itself has worked on a multi-phaseĀ researchĀ partnershipĀ with Pfizer and has filed IP on itsĀ proprietary system which can create healthy asĀ well as sick mini hearts and combines organoid data with AI to screen for drug toxicity and efficacy with an exceptionally high degree of accuracy.Ā As well as his work withĀ Novoheart, Dr. Costa is also the Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York. novoheart.comĀ |Ā Kevin.costa@novoheart.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
54:44
December 19, 2019
Episode 53: The Story of Diabetes Digital Media and Social Platforms šŸ‘©šŸ½ā€šŸ’»
This week, James is joined by Arjun Panesar, founding CEO of Diabetes Digital Media (DDM). Arjun founded Diabetes.co.uk whilst still a student at university in 2003 after his grandfatherā€™s quadruple heart bypass and diagnosis of type 2 diabetes. Since then, Arjun has led Diabetes.co.uk to become the worldā€™s largest diabetes support community. He holds a first-class honours degree (MEng) in Computing and Artificial Intelligence from Imperial College, London, with his award-winning Masters research demonstrating the benefit of intelligent systems in improving user experience through collaborative machine learning and data mining. Arjun's focus lies in empowering patients with innovative digital health services that augment traditional healthcare. Today, Arjun leads the development of DDMā€™s evidence-based digital health solutions which harness the power of big data, machine learning and behaviour change to provide precise and personalised patient care to patients. This is delivered through insurance companies, health agencies, and governments worldwide ā€“ including the NHS. This scalable, effective and engaging approach is redefining chronic disease and wellness, with over 1.2 million members across all platforms. ArjunĀ has written a book titled Machine Learning and AI for Healthcare which explores how artificial Intelligence and machine learning can be used to improve patient and population health.Ā Arjunā€™s book is due for release on 2ndĀ February via AmazonĀ https://amzn.to/2EAHCtv ddm.health | arjun@ddm.healthĀ |Ā https://www.linkedin.com/in/arjunpanesar/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
51:53
December 12, 2019
Episode 52: The Story of AccuRx and Clinician-Patient Communication šŸ“²
This week, James is joined by Jacob Haddad, cofounder of AccuRx, a UK-based startup using clinician-to-patient messagingĀ to bring patients and their healthcare teams together. They make patients healthier and the workforce happier. AccuRx raised Ā£8.8 million in Series A funding in February 2019 and their vision is for anyone involved in a patient's care to easily communicate with everyone else involved in that patient's care, including the patient. Their flagship product, Chain SMS, is used by GP practices to communicate with their patients. Chain SMS is completely free; the focus is on learning and developing ideas for powering communication across the healthcare workforce. It's now used in over 1 in 3 GP practices, all by word of mouth. On this weekā€™s episode, James and Jacob talk around a huge range of useful topics for entrepreneurs: bottom-up field sales in healthtech, pivoting and the importance of testing your assumptions with humility (AccuRx was originally built to solve a problem in antibiotic prescribing), business models in primary care (and tips for selling), innovative ways to get a customerā€™s attention and Jacob tells us of his key tips in healthtech: minimising time to value with every interaction and building a great experience for end-users. www.accurxcomĀ |Ā jacob@accurx.comĀ |Ā https://www.linkedin.com/in/jacobnhaddad/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
53:27
December 5, 2019
Episode 51: The Story of Infinity Health and Hospital Productivity šŸ„
How do you go from the post room at Virgin Records to becoming a healthtech entrepreneur? How does watching iTunes disrupting the music industry prepare you to disrupt healthcare? In healthtech, why is it so important to delight users with a great experience? All these answered and more on this week's episode where James is joined by Elliot Engers, founder and CEO of Infinity Health, a London-based start-up that has developed a suite of digital tools to improve workflow and task management in healthcare. Infinity Health was founded at the end of 2013 by Elliott and his cofounder, Dr Adam Benton. Elliot has an awesome background, coming from the music industry and watching iTunes disrupt the sector and he's now taken that learning into healthtech and is an expert in managing software products and services. In 2014 the company won a proof of concept grant from Innovate UK to develop digital tools for handover and task management. Over the years this has developed into Infinity Health, a digital platform that provides collaboration and task management for teams at the point-of-care. This takes the form of a suite of digital tools that collect and integrate data, for example patient lists and medical data, alongside tools to communicate this information such as notifications, instant messaging and activity feeds. www.infinity.health | hello@infinity.health | https://www.linkedin.com/in/elliottengers/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:00:32
November 28, 2019
Episode 50: The Story of Alpha, Women's Health and The Silicon Valley Formula šŸ‘©šŸ½ā€šŸ’»
What's the future of women's healthcare? Gloria Lau, cofounder and CEO of Alpha, believes that the future of health services and product delivery, whether prescription or OTC, insurance-covered or cash, will have a simple and personalised commerce experience supported by a team of AI-assisted doctors and pharmacies. Her current company, Alpha, is a health services brand that enables easy access to online diagnosis and prescription treatment, and focuses on healthcareā€™s primary decision makers - women. Alpha believes that the healthcare journey starts with basic medical needs - offering hormonal contraceptives, acne & anti-aging treatment, and elective cosmetic therapy. Alpha patients have access to a team of doctors and nurse practitioners, support for both insurance-covered and outside-of-insurance conditions, along with free shipping right to the patients home. Previously, Gloria headed up data products at Linkedin and was VP of Data at Timeful which was acquired by Google. She is also a consulting faculty at Stanford, holds a Ph.D. and MSc from Stanford Engineering & Computer Science, a BSc from UCLA Engineering, is the inventor on 11 patents in the area of recommendation systems and data science and is author of over 40 academic papers on information retrieval systems. gloria@helloalpha.com | www.helloalpha.com | www.av8.vc For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
50:29
November 21, 2019
Episode 49: The Story of Exscientia: The First AI Drug Discovery Company šŸ’ŠšŸ”
How does a night at the pub give you an idea for the first ever AI drug discovery company? Can you code how humans perceive beauty? Do you want the job title ā€˜Drug Hunterā€™ for your CV? Well, this week, James is joined byĀ Prof. Andrew Hopkins,Ā a leader in using AI in the hunt for medicines who will answer all of those questions. A bold claim, but one that can be backed up: Andrew invented the Artificial Intelligence approach to fix the very expensive, very slow, and very risky process of drug discovery, design and development. Andrew's company,Ā Exscientia, works with data scientists, chemists and machine learning engineers that mine huge amounts of data to bring new insights into what diseases are and how they can be treated. Their approach is currently shortening medicine discoveryĀ from 5 to 1 yearĀ and cutting the cost of drug development byĀ more than 30%.Ā Prior toĀ Exscientia, Prof. Hopkins spent 14 years at Pfizer, where he was frustrated with the slow pace of innovation - so he went back to Academia to foundĀ ExscientiaĀ as a spin out from his lab in 2012.Ā Since then,Ā ExscientiaĀ has discoveredĀ 4 pre-clinical drug candidates, with theĀ first drug design by algorithmĀ to enter human clinical trials imminently - and signed over 8 major pharma collaborations with companies such as Celgene, Sanofi, GSK and Evotec, estimated to be worth over $1 billionĀ in milestones and royalties. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
53:40
November 14, 2019
Episode 48: The Story of Skin Analytics and Dermatology AI šŸ§“ā˜€ļø
Can AI diagnose skin cancer as well as a dermatologist? The answer is yes and itā€™s was proved this month by my guest this week, Neil Daly from Skin Analytics. Itā€™s a UK based healthtech company whose DERM product featured in JAMA, The Journal of the American Medical Association for its ability to catch melanomas as sensitive and specific as a dermatology specialist. Skin Analyticsā€™ ambition is to help more people survive skin cancer by using their proprietary AI technology to improve access to high quality skin cancer screening. Neil started the company in 2012, having worked extensively in mobile innovation and strategy consulting for a number of years. He holds a BSc in Physics from the University of Western Australia and an Executive MBA from London Business School. Skin Analytics are working with a number of healthcare organisations in the UK and Australia and the recent study in JAMA was conducted across 7 NHS sites in the UK, led by the Royal Free London NHS Trust. neil@skinanalytics.co.uk | www.skinanalytics.co.uk JAMA Study: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2752995 For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
54:31
November 7, 2019
Episode 47: The Story of Butterfly, Imaging Technology & A $1.25 Billion Valuation šŸ¦‹
This week, James is joined byĀ Darius Shahida, Head of Growth & Chief of Staff at the $1.25 billion valued ultrasound company, Butterfly Network. Darius helps lead fundraising, global health, commercial and strategic efforts. In 2018, and while a student at HBS, Darius raised $250 million dollars for Butterfly Network - the largest medical imaging raise in history. Butterfly is fundamentally changing the way ultrasound is undertaken and you can read all about their brand new device in one of Jamesā€™ latest Forbes articles (link below) Darius was previously Head of Trading at a Birch Grove Capital, a Global Cross-Asset Hedge Fund which manages over $1BN. In this capacity he was responsible for all trading across Credit, Equities, Convertibles, Bank Debt and Commodities as well as helping the CIO in risk and portfolio management. Prior to Birch Grove, Darius built the Cross Asset Special Situations Desk at Morgan Stanley, where he was amongst the firmā€™s youngest hires. In this role, he was responsible for sourcing and structuring over $1BN in banking transactions and acted as the Firmā€™s specialist on Argentina during the default proceedings. Darius holds a MBA from Harvard Business School and a B.S from Duke University, where he studied Neuroscience and Psychology, and worked for Dan Ariely, one of the worldā€™s foremost Behavioral Economists. He speaks five languages, holds three passports and has lived and worked in New York, London, Buenos Aires and Sao Paulo. www.butterflynetwork.comĀ |Ā https://www.linkedin.com/in/darius-shahida-aa05a777/ | https://www.forbes.com/sites/jamessomauroo/2019/09/27/butterfly-a-125-billion-heathtech-company-launches-new-ultrasound-technology-in-the-uk For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
55:11
October 31, 2019
Episode 46: The Story Of Healthe & Blue Light Technology šŸ‘ā€šŸ—Ø
How bad is the blue light from your devices for your health? What technology is out there to combat it? How do you build a business tackling such an issue? This week, James is joined by Justin Barrett, CEO of Healthe, a company dedicated to improving eye health in a digital world, Healtheā€™s suite of products, technologies and Eyesafe brand are now being implemented by world leaders in consumer electronics. In partnership with the eye and healthcare community, electronic manufacturers and standards organizations, Healthe develops health-first technologies, standards and products. Justin was a recognized semi-finalist for Ernst & Young Entrepreneur of the Year with Healthe being ranked #5 on the Observer list of Hottest 20 Health Start-ups in 2019. He is a co-inventor on Healtheā€™s wide-reaching patent portfolio of light filtration technology for digital devices including accessory products, integrated display technology, augmented reality and VR. Previously, Justin was Entrepreneur-in-Residence at Fortune 100ā€™s Amtrust. Based in Minneapolis, Minnesota, he and the Healthe team develop technologies and standards in conjunction with the Eyesafe Vision Health Advisory Board including leading ophthalmologists and optometrists. justin@health-e.com | www.health-e.com HS. Health-Tech Talks Event, 31st October: https://www.eventbrite.com/e/hs-health-tech-talks-digital-health-tickets-76273475017Ā 
53:33
October 24, 2019
Episode 45: The Story of Cereproc and Speech Synthesis šŸ—Æ
What would you do with a cloned version of your voice? What if it sounded so real, it could turn text into jokes and even sing? What if someone cloned Her Majesty The Queen's voice? This week, James is joined by Dr. Matthew Aylett, a recognized world authority in speech technology research and development and was working at the International Computer Science Institute (ICSI) at Berkeley, California, before returning to Scotland in late-2005 to co-found CereProc. Matthew helps patients with conditions like throat cancers and neurological disorders to clone their voices and is exploring many other value propositions in health and healthtech. Prior to ICSI he was the senior development engineer at speech synthesis leader Rhetorical Systems (later acquired by Scansoft), which he joined at its formation. At Rhetorical, Matthew was responsible for the design, implementation, and testing of the company's core speech technology. Before Rhetorical, he spent five years at the University of Edinburgh researching speech and dialogue technologies. Dr. Matthew Aylett holds a BA in Computing and Artificial Intelligence from the University of Sussex, and an MSc with Distinction and PhD in Speech and Language Technology from the University Of Edinburgh. info@cereproc.com | www.cereproc.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
52:20
October 17, 2019
Episode 44: The Story of Bonzun and Pregnancy-Tech šŸ¤°šŸ½
This week, James is joined byĀ Bonnie RoupĆ©, a Swedish-born international businesswoman andĀ social entrepreneur, best known as the founder ofĀ Bonzun, a health company providing pregnant women and parents with unbiased evidence based medical information. In 2004, Bonnie started a publishing house and founded the Swedish Golf Magazine for women, Red Tee, the first niched sports magazine for women. In 2005 she was named the most promising entrepreneur of the Year in Sweden and in 2012 she was listed as one of Sweden's super talents. She was rewarded Innovation Against Poverty by SIDA 2012 for Bonzun's work spreading medical information in the countryside in China. In 2001 and 2003 Bonnie sailed on aroundĀ SvalbardĀ and fromĀ GreenlandĀ to the United States, making her one of few people to cross theĀ Arctic Sea,Ā Greenland Sea,Ā Labrador SeaĀ andĀ North Atlantic OceanĀ on a 47.7 feet sailboat! bonnie@bonzun.comĀ |Ā www.linkedin.com/in/bonnieroupe For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:00:24
October 10, 2019
Episode 43: The Story of Ieso Digital Health and NLP šŸ—£
Are you keen to learn the basics of AI and NLP? Are you looking to use NLP in your company? Could you? Should you? This week, James is joined by Valentin Tablan,Ā SVP for Artificial Intelligence at Ieso Digital Health which delivers high-quality cognitive behavioural therapy (CBT) online, for people experiencing common mental health issues. Valentin has spent nearly 20 years in the field of Natural Language Processing, Knowledge Representation, and Artificial Intelligence. His team apply advanced AI techniques to Iesoā€™s vast dataset to determine which evidence-based therapy interventions are most effective. Under his leadership, Ieso has created the industryā€™s first (real-time) AI-enabled tools that augment therapistsā€™ which in turn increases quality and improves clinical outcomes. Prior to joining Ieso Valentin was the lead scientist on the question-answering service that powers Amazonā€™s Alexa smart assistant; he is now using that expertise to help computers familiarise with the way patients express themselves during therapy. Valentin holds a PhD from the University of Sheffield and is a multi-lingual language specialist. He is a frequent speaker on deep learning tools and techniques which can revolutionise healthcare applications, medicine and diagnostics. www.iesohealth.com www.twitter.com/vtablan https://www.linkedin.com/in/vtablan/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
53:12
October 3, 2019
Episode 42: The Story of Natalie Douglas and Being A Healthtech CEO šŸ¤·šŸ¼ā€ā™€ļø
This week, James is joined by Natalie Douglas, who has over 20 years of experience in the pharmaceutical industry and healthcare services sector and is an award-winning business leader and entrepreneur. Following a sales and marketing career in the pharmaceutical industry, most notably at Johnson and Johnson, she led and secured an MBO, developed an executed an international growth strategy for the company, building a highly successful business and brand, establishing operations in North America, Europe and India.Ā  Natalie was the CEO of Healthcare at Home Limited from May 2014. She is also the founder of Lucidity LLC which is based out of New York.Ā  natalie@lucidity.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:01:52
September 26, 2019
Episode 41: The Story of Draper & Dash and Hospital Analytics šŸ„
How did a company go from selling luxury ties šŸ‘” to scaling predictive hospital analytics software? This week, James is joined byĀ Orlando Agrippa, CEO and founder of Draper and Dash, a London-based, Venture Capitalist (VC) backed healthcare AI and machine learning predictive data and analytics company. D&D leverages data from the public sector and private healthcare companies both nationally and globally and provides organisations with solutions that improve quality, safety, outcomes, efficiencies, and opportunities. Over the years D&D has worked with over 70 healthcare providers in Australia, the UK and US, helping them to drive cost improvements, form new strategic partnerships, improve health outcomes and more. Orlando has over 10 years of executive and CIO experience in the UK NHS system with relentless focus on the delivery of Clinical Systems, Business Intelligence and Analytics. Orlando spent time understanding the US healthcare system and also worked in Australia as an analytics transformation director. He has a proven track record of turnaround senior management success in both private and public sector organisations of varying scale and complexity. He has championed turnaround strategies within multimillion-pound organisations to drive up performance and visibility. Orlando is the only healthcare chartered luminary representative for Europe, with only 10 chartered luminaries globally. Orlando has Entrepreneurial experience of five acquisition, previous advisor and investor in Photodaze, M3, Bright North, Afrotherapy and Market Place City Swish.Ā  https://www.draperanddash.com orlando.agrippa@draperanddash.com https://twitter.com/OrlandoAgrippa https://www.linkedin.com/in/orlando-agrippa-39610587/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:03:23
September 19, 2019
Episode 40: The Story of Mojo and Fertility Technology šŸ¤°
This week, James is joined by Mohamed Taha, founder and CEO of Mojo Diagnostics. Mohamed has been a medical student, an engineer, an investor and is now an entrepreneur. His journey to entrepreneurship started with a misdiagnosis during his PhD in Lyon, meaning he underwent fertility testing thwart with problems and inaccuracies. This led Mohamed to explore the issue and eventually build a company to solve the worldwide problems. Mojo applies artificial intelligence to semen analysis, which is used to determine a manā€™s fertility. Today, diagnostic semen analysis is a very time consuming manual process requiring a highly trained professional. Using AI, Mojo is able to make the analysis easier, increasing the number of sperm that are counted and assessed. Mojo therefore assists in improving accuracy and producing reliable results, in a fraction of the time. On the podcast, James and Mohamed talk about his journey, perceptions of fertility issues, the technology needed both now and in the future and how to get investment when youā€™re trying to create a new market. https://www.mojo-diagnostics.com/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
54:21
September 12, 2019
Episode 39: The Story of Philips and Healthtech Corporates šŸ’”
Ever wondered how a technology giant like Philips thinks about healthcare and healthtech? This week, James is joined byĀ Jan Kimpen,Ā Chief Medical Officer at Philips. As the leader for clinical strategy,Ā JanĀ works in close collaboration with health system customers to deliver health technology solutions that support better health outcomes and experiences at lower-cost. A former hospital CEO and Professor of Paediatrics,Ā JanĀ is an expert on digital innovation in healthcare with deep expertise on data management and artificial intelligence, precision medicine, telehealth and advanced homecare. JanĀ is also the lead spokesperson for Philipsā€™Ā Future Health IndexĀ (FHI), a yearly study surveying healthcare professionals and the general populations in 15 countriesĀ to determine the readiness of nations to address global health challenges and build sustainable health systems. Ā Jan and James talk about Jan's career, how Philips think about healthtech startups, how they're acquiring companies and the implications of the FHI report. https://www.healthworks.philips.com/ is the Philips start-up engagement teamā€™s webpage which includes a submission form for enabling startups to contact them. https://www.philips.com/a-w/about/news/future-health-index is the Future Health Index landing page for those keen to read up on the report. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
57:18
September 5, 2019
Episode 38: The Story of Scalpel and Tech in Surgery šŸ˜·
This week, James is joined by Dr. Yeshwanth Pulijala, artist, dentist and entrepreneur. He describes himself as a generalist who builds technologies that improve healthcare. During his PhD in VR and AR applications in healthcare, he designed and evaluated one of the first immersive virtual reality training tools for Oral and Maxillofacial Surgery. After training as a dentist, he gained over five years of interdisciplinary experience in healthcare and technology (Virtual Reality, Augmented Reality and Computer Vision). He previously built a startup (Open Simulation) to provide low-cost surgical simulation using Augmented Reality, using his understanding of healthcare challenges from a clinical point of view and building tools to address those needs. Currently, he is focused on making surgery safer through Scalpel Ltd., building a non-invasive sensing platform for hospitals to improve patient safety, prevent serious incidents and reduce costs. Their proprietary system detects and prevents errors in real-time during an operation using a combination of deep learning and sensor fusion techniques. http://scalpel.ai/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
51:38
August 29, 2019
Episode 37: The Story of Jud Brewer, Digital Therapeutics and Mindful Tech šŸ“±
James is joined by Dr. Jud Brewer who holds the position of 4th most watched TED talk in 2016, with 12 million views. Jud is founder of MindSciences Inc developing digital therapeutics in the area of addiction, he is Director of Research and Innovation at the Mindfulness Center and associate professor in psychiatry at the School of Medicine at Brown University and research affiliate at MIT. Heā€™s also held research and teaching positions at Yale University and the University of Massachusettsā€™ Center for Mindfulness. As an addiction psychiatrist and internationally known expert in mindfulness training for treating addictions, Dr. Jud has developed and tested novel mindfulness programs for habit change, including both in-person and app-based treatments for smoking, emotional eating, and anxiety (Eat Right Now, Unwinding Anxiety and Craving to Quit). Based on the success of these programs in the lab, he co-founded MindSciences, Inc. to create app-based digital therapeutic versions of these programs for a wider audience, working with individuals, corporations, and hospital systems to put effective, evidence-based behaviour change guidance in the hands of people struggling with unwanted behaviours and ā€œeveryday addictions.ā€ James and Jud cover lots of topics - all of the above, plus commercialising academia, Buddhist psychology, the science of mindfulness and how to harness technology to exploit it and the doā€™s and donā€™ts of building a digital therapeutics company. https://www.drjud.com/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
51:45
August 22, 2019
Episode 36: The Story of Dexcom and Diabetes-Tech šŸ°
James is joined byĀ Jake Leach, Chief Technology Officer at Dexcom. Jake oversees the development of next generation products and his teams are responsible for delivering best in class glucose monitoring technology paired with an exceptional user experience. Jake joined Dexcom in March 2004 to lead development of sensor electronics which were part of the first generation Dexcom system. Jake has served in various roles within Dexcom including Senior Vice President of R&D, Senior Director of R&D, and Manager of Engineering. From 1996 to 2004, Jake held positions in research and development at MiniMed and subsequently Medtronic Diabetes, focusing on the development of glucose sensing systems. Jake holds a Bachelor of Science degree in Electrical Engineering with a minor in Biomedical Engineering from the University of California, Los Angeles. James and Jake talk about how Jakeā€™s background in engineering and his inquisitive mind set him up for a career in medical devices, how MiniMed and Dexcom scaled so fast and why the diabetes-tech space is so exiting right now. www.dexcom.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
55:15
August 15, 2019
Episode 35: The Story of Flagship Pioneering and The Future of Medicines šŸ§Ŗ
James is joined by Dr. Paul-Peter Tak, Venture Partner at Flagship Pioneering and CEO of Kintai Therapeutics.Ā Over a more than 25-year career in the life sciences, Paul-Peter has created and led multiple companies. From 2011 until 2017, Paul-Peter founded and served as senior vice president and head of the immuno-inflammation therapy area unit at GSK. Under Paul-Peterā€™s leadership, this unit brought more than 10 new mechanisms of action into the clinic. From 2016 until 2018, Paul-Peter was senior vice president of R&D pipeline, chief immunology officer, development leader, and co-chair of GSKā€™s scientific review board. He oversaw the creation of a new portfolio of medicines in oncology, with a focus on immuno-oncology, epigenetics, and cell and gene therapy.Ā  Trained as a general internist, rheumatologist, and immunologist, Paul-Peter has held multiple professorships and has published extensively, with more than 550 papers in his name. He served as professor of medicine and chair of the department of clinical immunology and rheumatology at the Academic Medical Centre/University of Amsterdam for twelve years. He is a professor of medicine at the Amsterdam University Medical Center, honorary professor of rheumatology at Ghent University, and honorary senior visiting fellow at the University of Cambridge. He is a fellow of the Academy of Medical Sciences in the U.K.Ā  Paul-Peter received his medical degree cum laude from the Free University in Amsterdam and his Ph.D. from Leiden University Medical Center.Ā  https://www.flagshippioneering.com/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
59:52
August 8, 2019
Episode 34: The Story of BIOS & Hacking The Human Brain šŸ§¬
Can we one day hack the human brain? That day might be sooner than you think... This week, James is joined by Emil Hewage, Co-Founder and CEO at BIOS. Emil undertook PhD research in computational neuroscience and machine learning at the University of Cambridge and has used this knowledge to pioneer the use of artificial intelligence for interpreting neural data. He began working in startups at age 17 and held engineering and leadership roles across a range of industries from clean energy to advanced medical technologies. He was recently named to Forbes 30 Under 30. BIOS is a leading neural engineering startup, creating the open standard hardware and software interface between the human nervous system and AI. Their team uses applied materials, machine learning, software engineering, neuroscience, and the experience of surgeons and clinicians to solve the complex problems of successfully integrating AI-based treatments into the human body. BIOS has the largest PNS neural data set in the world, performing cutting-edge machine learning research to apply this technology to chronic conditions throughout the body, enabling a new ecosystem in healthcare from delivery to recurrent care. The company was formerly known as Cambridge Bio-Augmentation Systems (CBAS) and they've recently raised $4.5 million in seed funding. https://www.bios.health/
49:31
August 1, 2019
Episode 33: The Story of Teckro and Innovating Clinical Trials šŸ’Š
James is joined by Gary Hughes, CEO and co-founder ofĀ Teckro. Gary founded Teckro with his brother,Ā NigelĀ Hughes, and CTO Jacek Skrzypiec. Teckro uses machine learning to help get drugs and treatments to market quicker and more transparently by speeding up clinical trials - they're working with the top 10 pharmaceutical and biotech companies in the world and their platform takes pressure off doctors, nurses and drug developers and ensures treatments get to market quicker. TeckroĀ raised $25million recently in a Series C to bring their total funding to $43 million from top VCs like Founder's Fund and Bill Maris. Their HQ is Limerick, Ireland with an engineering hub in Dublin and an office in Nashville. TeckroĀ now has nearly Ā 12,000 active sites worldwide and on the podcast, James and Gary talk about Teckro's growth, their funding rounds and how to innovate in clinical trials.
58:50
July 25, 2019
Episode 32: The Story of GlaxoSmithKline and the Importance of Design In Healthtech šŸ§¬
James is joined byĀ Andrew Barraclough, VP of design and innovation at GlaxoSmithKline.Ā With thirty yearsā€™ experience, Andrew Barraclough is a leading voice at the heart of design and innovation in the healthcare and FMCG sectors. Andrew joined GlaxoSmithKline in 2011, having previously worked Design Business Association, Novartis Consumer Health, Reckitt Benckiser and Pure Realisation, which he founded. As Vice President of design and innovation at GSK, Andrew has continued to push the boundaries of perception of design across 146+ markets for 25+ global brands, including Panadol, Sensodyne, Theraflu and Flonase. Andrewā€™s mission at GSK is to embed world class design-thinking and culture across all customer touchpoints. Andrew and James talk about the importance of design in healthtech, how to apply design thinking, the value of designers to healthtech startups and all startups need to apply design thinking from day one. https://www.gsk.com/
53:28
July 18, 2019
Episode 31: The Story of Xenzone and Digital Mental Health šŸ§˜šŸ½ā€ā™€ļø
James is joined byĀ Zoe Blake, CEO of Xenzone. Zoe is on a mission to provide improved access to clinically excellent mental health services across England and beyond via digitised counselling - powered by humans and backed by AI and analytics. Her rich background in technology and leadership, and the personal tragedy of losing her mother - a mental health nurse - to suicide are what drive her to use technology for clinical good. She has built XenZone into the largest digital mental health platform in England, available in its 100th NHS Clinical Commissioning Group (CCG) area - making its services free for children and young people across more than half of England and making substantial impact to the current NHS landscape. James and Zoe talk about Zoeā€™s background and her 25 years in tech businesses, her personal experience of mental ill health in her family, why you shouldnā€™t judge a company by what they raise, how she has scaled Xenzone and how digital could be the answer to the huge demand for mental health services. https://xenzone.com/
52:15
July 11, 2019
Episode 30: The Story of Vincent Grasso, A Wall Street Legend and Extreme Telemedicine šŸ”
This week, James is joined by Vincent Grasso, a surgeon, software architect and medical informaticist. Heā€™s currently Global Practice Lead for IPSoft where he designs Cognitive Health Agents and their integration by leveraging the ā€˜Amelia' virtual agent. Vincent completed his surgical residency at the Mount Sinai School of Medicine Manhattan Program and whilst at Yale University on a fellowship programme, he worked with NASA on Extreme Telemedicine, effectively putting an ER at basecamp of Everest in the 1990s and pioneering the field of telemedicine. Vincent has previously built his own EMR, heā€™s built startups, he's been mentored by a Wall Street Legend and he's passionate about solving the opioid crisis with technology. James and Vincent talk about all of this and more on this week's episode.Ā 
55:40
July 4, 2019
Episode 29: The Story of Endomag and Nanotechnology šŸ¤–
James is joined by Ā Eric Mayes, serial nanotechnology entrepreneur and CEO of Endomag. Ā Eric has 20 years of experience in technology. He was named the Royal Society of Chemistryā€™s ā€˜Entrepreneur of the Year 2003ā€™ for his founding role in NanoMagnetics. He is also an advisor to the University of Texas at Austinā€™s ā€˜Texas Health Catalystā€™ and the European Healthtech Translation Advisory Board (HealthtechTAB). Ā Eric believes that everyone deserves a better standard of cancer care and so joined Cambridge-based healthtech start-up Endomag as CEO. They manufacture a metallic seed, smaller than a grain of rice, which uses magnetism to help doctors locate breast cancer tumours to be removed. James and Eric chat about Eric's previous companies, his journey to healthtech and discuss some lessons learned in adoption of new innovation across healthtech. http://www.endomagnetics.com/
56:37
June 27, 2019
Episode 28: The Story of Birdie and AgeTech šŸ‘“šŸ»
James is joined by Max Parmentier, founder and CEO of Agetech startup, Birdie. Max has previously scooped $15M from investors including Bill Gates to work on start-up Wambo, an Amazon-esque marketplace that pools medicine procurement so developing countries can get cheaper drugs.Ā Heā€™s pitched at the White House, and worked at the UN; heā€™s done five years at McKinsey and even helped the government of the Democratic Republic of the Congo to plan against deforestation ā€” all before he was 30.Ā Birdie recently raised a $7M Series A and digitalises notes taken by care workers during visits which can be more easily shared between professional carers, other health practitioners and family members, helping to coordinate care and keep an older generation out of care homes or hospital beds. But the vision goes much wider and on the podcast, Max talks about tackling the stigma of ageing and normalising support in peoples' homes and James and Max chat about social purpose and meaning in healthtech, how Birdie plans to capture the agetech sector and how to build a truly socially conscious company.
1:00:25
June 20, 2019
Episode 27: The Story of Albion VC and the History of Healthtech ā³
This week James is joined by Andrew Elder, Deputy Managing Partner at Albion VC. Andrew initially practised as a surgeon for six years, specialising in neurosurgery, before joining the Boston Consulting Group (BCG) as a consultant in 2001. Whilst at BCG he specialised in healthcare strategy, gaining experience with many large, global clients across the full spectrum of healthcare including biotechnology, pharmaceuticals, service and care providers, software and telecommunications. Andrew now focuses on medical technologies, digital health and technology-enabled services to the life-science sector, and has served on the boards of companies ranging from diagnostics, imaging and software to pharmaceuticals and biomarkers. He joined Albion Capital in 2005 and became a partner in 2009. He has an MA plus Bachelors of Medicine and Surgery from Cambridge University and is a Fellow of the Royal College of Surgeons (England). Andrew also oversees the management of the UCL Technology Fund in collaboration with UCLB.Ā  https://www.albion.vc/
1:07:53
June 13, 2019
Episode 26: The Story of Elvie, Femtech and a $42M Raise šŸšŗ
James is joined by Tania Boler, the cofounder and CEO of Elvie, a health and lifestyle brand developing smarter technology for women. Elvie takes the best of medical technology and turns it into premium consumer products that women love to use. Together with her co-founder, Alex Asseily (co-founder, Jawbone), she has raised > $50M in investment, most recently their $42M Series B round led by IPGL and supported by Octopus Ventures and Impact Ventures UK. Ā Their first product, Elvie Trainer, is a category-defining Kegel trainer and is sold in major retailers, including Nordstrom and John Lewis and their latest product is the Elvie Pump, a breast pump that made its debut on the catwalk at London Fashion week. James and Tania talk about her background, coming from UN policy into entrepreneurship, the importance of design in healthtech, how to launch a B2C medical device and the ever growing femtech space in health.Ā 
48:23
June 6, 2019
Episode 25: The Story of Cognetivity and AI Dementia-Tech šŸ§ 
James is joined by Sina Habibi, founder and CEO of AI dementia-tech startup, Cognetivity. Sina simplifies complex challenges and develops compelling and collaborative ways to solve them and in addition to business executive roles he has experience in research (nano-technology and synthetic biology), product management, and high-tech consultancy (big data and fin-tech). Sina has been an active member of Cambridge University Entrepreneurs (CUE) since 2010 and chaired the society in 2013-2014. Cognetivity has patented and pilot-tested a software-based platform technology for assessing mental health. Early diagnosis and management of cognitive disorders, including dementia, holds the promise of transforming peoplesā€™ lives and bringing clarity to international healthcare management provision. The early diagnostic sector is starting to gain significant commercial interest as it offers metrics to the pharmaceutical industry in the development of new therapeutics. Additionally the markets for early screening and home monitoring offers significant health economic benefit to payors. https://www.cognetivity.com/
48:55
May 30, 2019
Episode 24: The Story of Mir Imran, Medical Devices and Big Exits šŸ‡®šŸ‡³
James is joined by Mir Imran, an Indian healthtech inventor, entrepreneur and venture capitalist. He has had over 20 medical device companies that he has sold to the likes of Ely Lily, Medtronic and Abbott. His first medical device was a world first - the implantable cardiac defibrillator (ICD), which, after being spun out, was acquired by Boston Scientific for $27bn. Ā Mir invented the BIS monitor, used to measure depth of anaesthesia, the Dorsal Root Ganglion (DRG) Stimulator and many other devices. He now has an applied research institute and a venture fund for medical devices and you can hear his fascinating story right here. https://www.incubevc.com/team/mir/
57:24
May 23, 2019
Episode 23: The Story of Big White Wall & Mental-Health-Tech In Elite Sport āš½ļø
It's Mental Health Awareness Week and James is joined by Dr. Tim Rogers, who is a medical doctor, consultant and sport psychiatrist. He regularly consults with elite athletes in the UK across a wide variety of sports, including athletes involved in Olympic and Paralympic competition. Tim is a leading advocate for the promotion of athlete wellbeing and mental health and recently joined mental-health-tech company, Big White Wall, as Clinical Director. James and Tim discuss his journey into technology and how new mental-health-tech is reshaping the way that athletes and others are accessing mental health services. https://www.bigwhitewall.com
45:29
May 16, 2019
Episode 22: The Story of One Healthtech Entrepreneur and 100M Patients šŸ‘©šŸ¼ā€šŸ”¬
James is joined by Robin Farmanfarmaian - healthtech expert, global speaker and author of Amazon No.1 bestseller The Patient as CEO: How Technology Empowers the Healthcare Consumer. Robin is an angel investor in healthtech, backing companies like Dance Biopharm who are doing clinical trials for an inhaled insulin vaporised from a liquid and unicorn MindMaze VR who have raised >$100M (in part from Leonardo di Caprio) and are valued at $1B. Robin talks about her younger years dealing with an autoimmune disease and how she became motivated to positively impact 100M patients through healthtech innovation, how she built an ecosystem round herself through giving and adding value to others and how through her new book, The Thought Leader Formula, she's teaching others in health to become exactly that. https://www.robinff.com/
47:23
May 10, 2019
Episode 21: The Story of Speedo, Nike and eConsult #justdoit šŸ…
This week, James is joined by Mark Harmon, who originally studied pharmacology before becoming a buyer for M&S - he was there for 7 years travelling the world. He then worked for Arcadia Group, which includes the likes of Miss Selfridge and TopShop, opening up flagship shops in places like Rio, and because loves sport, he moved to speedo to set up Speedo Beach, which was a business within a business that grew to about $20M in 3 years - he had a team in Australia and some other incredible beach locations around the world, before getting headhunted by Nike to run their $100M sports apparel business globally and worked with the likes of Wayne Rooney, Roger Federer and Rafael Nadal. Mark then had a very moving personal experience Ā when his son born unwell and his priorities in life change pretty much overnight so he went on to become the oldest medical student through Kings College Medical School, graduated as a doctor and went on this great journey to combine his business and medical acumen to now work for eConsult - a healthtech company that streamlines primary and urgent care through an online consultation platform. www.econsult.net
1:01:39
May 6, 2019
Episode 20: The Story Of Sleepio and Scaling Into The USA šŸ’¤ šŸ‡ŗšŸ‡ø
This week, James is joined by Peter Hames, cofounder and CEO of Big Health, a healthtech company that creates digital programmes to help those with mental health conditions. Not wanting to enter into the potentially vicious cycle of taking medications to help him sleep, Peter, a psychologist by background, was inspired and motivated to start the company when he saw the market lacked any evidence-based, non-drug solutions for his insomnia. Big Healthā€™s first product is, therefore, Sleepio, which is a digital sleep improvement program delivered online or via their app. It gives users techniques from a treatment method called Cognitive Behavioural Therapy (CBT), which means that patients like Peter, who don't want to take sedative medications, can receive an alternative, proven, evidence-based therapy.Ā James and Peter talk about Peter's background as an insomnia sufferer, his awesome founder story and how an innovative business model has led to Sleepio beingĀ availableĀ to 12 million people globally. Read Peter's Forbes interview - https://bit.ly/2ZxgnbvĀ  www.sleepio.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
55:22
April 26, 2019
Episode 19: The Story of Nurokor and Bioelectric Medicine āš”ļø
This week, James is joined by Rick Rowan, the patient-founder of Nurokor, a company that creates pain-relieving products that use a technology called microcurrent. Their first product is a device that looks pretty similar to a smartphone, with small electrodes attached that are put onto the skin. It's a Class IIa medical device, FDA approved, CE marked and is selling into 5 different countries, with sufferers of many forms of chronic pain, including Olympic athletes, shouting about positive results. James and Rick talk about Rickā€™s background as a chronic back-pain sufferer, his motivations from seeing family members in pain to combatting the opioid epidemic and how initially selling B2C has helped the business across healthcare. https://www.nurokor.com/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
46:08
April 20, 2019
Episode 18: The Story of Thriva and Consumer Health šŸ’‰
This week, James is joined by Hamish Grierson, founder and CEO of Thriva, who has raised over Ā£6M to provide a home-blood-testing service to UK consumers (and now some NHS patients). Hamish is a serial entrepreneur and moved into healthtech from fintech and talks about his journey and some of the similarities and differences between the two sectors. Hamish will also be appearing in the Forbes Healthtech Stories series in May, so look out for that shortly. www.thriva.coĀ  For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
49:36
April 12, 2019
Episode 17: The Story of 'Smoke Free' and Behavioural Psychology in Healthtech šŸš¬šŸ§ 
This week, James is joined by David Crane, founder and CEO of Smoke Free to talk about how becoming a psychologist led to the creation of the Smoke Free app and gives a lesson to all entrepreneurs in how implementing the theory of behavioural psychology has led to it being downloaded over 4 million times. David is a long-time entrepreneur and has previously founded a development agency, making over 400 apps and websites, a debating association, a company that created insights out of online community forums/blogs and even a cannabis cafe. Ā www.smokefree.aiĀ  For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
52:31
April 5, 2019
Episode 16: The Story of Health Tech Investing and Octopus Ventures šŸ™
This week Alex and James are joined by Gian Seehra an investor at Octopus Ventures to talk about transitioning from entrepreneur to venture capital, health tech investments and how both founders and investors should approach setting early valuations. Gian focuses on health investments at Octopus and splits his time on deal origination and assessment of investment opportunities. Prior to joining Octopus, Gian spent two years in Canada building a biotechnology company called Pebble Labs tackling vector-borne, animal and plant diseases, and Trait Biosciences within the cannabis industry. Gian holds a degree in Industrial Economics from the University of Nottingham. He spent two months training in Muay Thai Boxing in Thailand and plans to spend two weeks a year training there. Octopus Ventures are one of Europeā€™s largest Venture Capital teams with Ā£1bn under management. Octopus is a generalist fund but with specialist investments in health-tech. Based in London and New York, they have Venture Partners in San Francisco, Singapore and China. Their typical initial investment is from Ā£1m for Seed to around Ā£5m for Series A. https://octopusventures.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
47:52
March 31, 2019
Episode 15: The Story of Public Health and Lifestyle Medicine
On today's episode Alex and James are joined by Dr Sohaib Imtiaz M.D., MPH, VP of Innovation at Owaves, a company that aims to optimize your circadian rhythm through calendar-tracked lifestyle modification. Sohaib is a board-certified physician in lifestyle medicine from the United Kingdom who ranked among the top 10 students nationally in statistics, business studies, and information technology. He focuses on lifestyle medicine while exploring technology, innovation, and entrepreneurship. Sohaib chose to study in his hometown of Manchester in order to prioritize his well-being and relationships. He believes in prevention and in ā€˜Supra-Health,ā€™ the ability to optimize our health. The team discuss the journey of transitioning from clinician to entrepreneur, public health and lifestyle medicine. https://twitter.com/digitald0ctor https://owaves.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
1:07:13
March 23, 2019
Episode 14: The Story of A Patient Who Made A Medicines App Sexy
Stephen Bourke is cofounder of the UK medicines-management and digital pharmacy app, Echo. Not wanting to be defined by his own medical condition, Stephen, a lifelong patient, embarked on a journey to build a solution that empowers patients and puts them in control of their medications, improving adherence rates and making life with a chronic condition much easier. Since its creation in 2016, Echo has gone on to scale nationally and has helped tens of thousands of people to stay well. With Stephenā€™s firm belief in patient centred-design, along with his background in branding and a team comprised of alumni from Apple, Lyst, Hello Fresh and Badoo, they might have proved that you can, in fact, make a medicines app sexy. We chat design, disruption and digitising the UK health service. Notes: Stephen mentions The Spine, which, for those that don't know, supports the IT infrastructure for health and social care in England, joining together over 23,000 healthcare IT systems in 20,500 organisations. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
46:33
March 15, 2019
Episode 13: The Story of Mentorship To Turn An Idea Into Reality
James is joined by Will Stoddart, a Medical and Tech CEO, with experience founding, growing and scaling Werlabs, a rapidly expanding healthcare internet business based out of Stockholm, Sweden. Prior to Werlabs, Will was a founder, along with his twin brother, at Haploflow; focusing on helping individuals make decisions based on data from wearables. Will has experience across software engineering, medicine and finance - plus a few war stories on founding, raising financing and managing very different cultures: think medicine vs product vs marketing. Currently, Will is founding a new consumer healthcare company that is focusing on monitoring, educating and treating age-related decline in functionality. They cover Will's background, overcoming tragedy, his companies, motivations and passion to solve problems in health. Will gives a practical guide to starting a company, setting up a board, how to streamline the process, mentoring and being mentored and also explains why the tech ecosystem in Stockholm is so powerful. Podcast references: - Monkeyglandin.com - How To Stay Young, BBC - The Hidden 40%, Andreessen Horowitz - Physician Innovators, Andreessen Horowitz - The Hard Thing About Hard Things, Ben Horowitz - Daniel Eck, CEO of Spotify - Jonas Norlander, Founder of Avito - Bridgewater's Ray Dalio On The Value Of Embracing Your Weaknesses For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo a5JLhnPM0MwY7xN93CU1
45:17
March 1, 2019
Episode 12: The Story of Medopad and Global Scale
James is joined by Alex Gilbert who currently manages large Life Sciences Partnerships at Medopad, one of the UKā€™s highest-growth digital health companies. Alex is an experienced ā€œJack of all tradesā€ who has been working within the Digital Health industry alongside healthcare, pharmaceutical and tech organisations. Through his experience at Medopad, he has launched national projects, defined product proposition and helped grow the company from 8 to >100 people. His passion is the use of technology to empower and engage the patient to take control of their care. The team talk about Alex's background, how he got into digital health, the value of partnerships with the likes of Apple, Medopad's $28M raise, how Alex has helped Medopad scale internationally and Alex's view on the future of the healthtech sector. www.medopad.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
48:11
January 23, 2019
Episode 11: The Story of Healthtech Entrepreneurship to Venture Capital
This week, James is joined by Zoe Peden, an experienced healthtech entrepreneur-turned venture capitalist at Ananda Impact Ventures. They discuss Zoeā€™s journey as founder of social care startup, MyChoicePad; how being driven by impact led her to VC and what she looks for in companies as an investor. Zoe holds an undergraduate degree from LSE, an MBA from Henley Business School and is a visiting lecturer at Cass Business School. She has a particular interest in deep technology for impact and now looks to invest in companies that address social challenges in vital areas such as education, health, consumption and the ageing population. www.ananda.vcĀ  For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
45:43
January 16, 2019
Episode 10: The Story of Styliff, User-Centric Design and Sports-Tech
This week James is joined by Charlie Regis the co-founder of Styliff Tech. Styliff is an award winning London & Slovenia based development company who pride themselves on perfecting technology in style. Charlie became European Doubles Champion in Tennis with co-founder Lucas in 2012. He worked at Bastion PR Agency in sports sponsorship and earned his BSc in International Business from Loughbrough University.Ā  For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
49:24
January 6, 2019
Episode 9: The Story of Healthcare Regulation and Innovation
This week James is joined by Eric M. Fish who is the Senior Vice President of Legal Services at the Federation of State Medical Boards and serves as the general counsel for the organization. Eric also assists in the FSMB's federal and state advocacy efforts, analyzing legislation and healthcare trends, and consulting on the development of model policies for state medical boards. His current work includes exploring how regulated industries and healthcare will respond to the integration of artificial intelligence, as well as pioneering the use of new technologies to improve the licensure and credentialing process. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
44:06
December 22, 2018
Episode 8: The Story of Perfect Ward and Quality Improvement
Alex and James are joined by Jonathan Knight co-founder of Perfect Ward, an app that makes health and quality inspections easy and effective, across hospitals, care homes and community services. Jonathan has a background in management consultancy, specifically healthcare consulting and founded Perfect Ward to solve key issues he identified with the inspections reporting chain. We talk about the service side of healthcare, quality improvement and staying focused in the face of emerging technology. https://www.perfectward.com/ For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
45:51
December 10, 2018
Episode 7: The Story of Q Doctor and Telehealth Safety
Alex, James and Nathan are joined by Dr Chris Whittle CEO and Founder of Q doctor an online video doctor service providing safe, secure, instant and easy to use video GP consultations from your PC or smartphone. Q doctor supports GP practices directly and has been declared safe, effective, caring, responsive and well-led by the Care Quality Commission (CQC) after a full inspection. The team discuss the journey of an early founder, selling into public health systems and ensuring that technology companies put policy and patient safety first. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
48:30
November 25, 2018
Episode 6: The Story of Babylon and Healthcare Sustainability
Alex and James are joined by Dr Umang Patel, partnerships and clinical director at Babylon Healthcare who's mission is to put an accessible and affordable health service in the hands of every person on earth. At Babylon, Umang spends his time making sure that safe, effective and personalised healthcare is available to everyone, everywhere. Umang is also an NHS Paediatrician, he can be found treating children at Frimley Park Hospital on Fridays. The team talk about saving money and the costs of delivering healthcare, what makes a good healthcare company and the importance of culture when companies scale. www.babylonhealth.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
44:28
November 18, 2018
Episode 5: The Story of Respond and Dementia-Tech
Callum Bramley Founder and CEO of Respond joins Alex, James and Nathan on the podcast. Callum studied robotics and AI at the University of Reading and founded Respond to help patients with early-stage dementia; helping to identify subtle signs a person may exhibit to help improve detection. The team discuss dementia, computer vision and parallels between health-tech and the fashion industry. www.respondapp.co For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
42:07
November 11, 2018
Episode 4: The Story of Feebris and AI in Healthcare
Alex, James and Nathan are joined by Dr Elina Naydenova and Adam Bacon the founders of Feebris an AI-powered system that democratises access to high quality diagnostic and monitoring services beginning with respiratory disease. Elina is a biomedical engineer and data scientist PhD at Oxford University and has also spent time at the World Health Organisation while Adam comes from a strong product background having worked in large corporate supply chains. The team discuss everything about AI in healthcare from regulation and the latest advances to how to ensure high accuracy of data sets together with the role of submarines and samosas. http://feebris.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
49:14
November 3, 2018
Episode 3: The Story of Health-Tech Angel Investing and Startup Finances
In this episode Alex and James are joined by health-tech angel investor Robert Van Der Zalm. Robert is a globally experienced executive with a strong financial and M&A background and ex-CFO of Noble group a $90bn turnover commodity trader. The team discuss angel investing from both the angel and entrepreneur's viewpoint, startup finances and offer helpful tips around raising angel investment rounds in health-tech. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
44:16
October 26, 2018
Episode 2: The Story of Vesalian, GPDQ, Primary Care-Tech and Behavioural Science
Alex, James and Nathan are joined by Dr David Neale CEO & Founder of Vesalian and Paul Roberts CEO of GPDQ. The team and guests discuss integrating tech into primary care and discuss David's background in behavioural science and why it is vital for digital health adoption by both patients and physicians. www.hs.live www.vesalian.com www.gpdq.co.uk For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
48:16
October 22, 2018
Episode 1: The Story of Health-Tech and HS.
In this episode Alex, James and Nathan talk a little about their own back-stories and how HS. came to be created. The team discuss the current key technologies in healthcare, the importance of having a technical co-founder in your early stage health-tech company, the latest digital health investments and how to create a product that patients love that providers will pay for. For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.liveĀ  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
45:50
October 13, 2018